Literature DB >> 29362984

Clinical significance of hWAPL polymorphisms in the risk of cervical carcinogenesis.

Osamu Nunobiki1, Daisuke Sano2, Sakae Hata2, Toshitada Ogasawara3, Masatsugu Ueda4.   

Abstract

To investigate the clinical significance of human wings apart-like (hWAPL) genetic polymorphisms in cervical carcinogenesis. hWAPL polymorphisms and human papillomavirus (HPV) types were examined in 175 cervical smears of exfoliated cervical cell samples using a real-time polymerase chain reaction system. A significant difference was detected in the frequency of the CC genotype between the HPV(+) low-grade squamous intraepithelial lesion (LSIL) and high-grade squamous intraepithelial lesion (HSIL) groups [Odds ratio 0.21, 95% confidence interval (CI) 0.0723-0.61; P = 0.0029]. A significant difference was noted in the frequency of the CC genotype between the high-risk HPV-positive LSIL and HSIL groups (odds ratio 0.2955, 95% CI 0.0893-0.9771; P = 0.0414). The CC genotype of hWAPL gene promoter polymorphism may be associated with cervical carcinogenesis.

Entities:  

Keywords:  Cervical carcinogenesis; Polymorphism; SIL; hWAPL

Mesh:

Substances:

Year:  2018        PMID: 29362984     DOI: 10.1007/s13577-018-0200-7

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  25 in total

1.  MDM2 SNP 309 human papillomavirus infection in cervical carcinogenesis.

Authors:  Osamu Nunobiki; Masatsugu Ueda; Michiko Yamamoto; Eisaku Toji; Naomi Sato; Shinji Izuma; Yoshiaki Okamoto; Kiyo Torii; Sadamu Noda
Journal:  Gynecol Oncol       Date:  2010-06-09       Impact factor: 5.482

2.  Human Wapl is a cohesin-binding protein that promotes sister-chromatid resolution in mitotic prophase.

Authors:  Rita Gandhi; Peter J Gillespie; Tatsuya Hirano
Journal:  Curr Biol       Date:  2006-11-16       Impact factor: 10.834

3.  Induction of chromosome abnormalities in mouse and human epidermal keratinocytes by the human papillomavirus type 16 E7 oncogene.

Authors:  T Hashida; S Yasumoto
Journal:  J Gen Virol       Date:  1991-07       Impact factor: 3.891

4.  Association of multiple human papillomavirus types with vulvar neoplasias.

Authors:  H Nagano; H Yoshikawa; T Kawana; H Yokota; Y Taketani; H Igarashi; H Yoshikura; A Iwamoto
Journal:  J Obstet Gynaecol Res       Date:  1996-02       Impact factor: 1.730

5.  Effects of 3-methylcholanthrene on the transcriptional activity and mRNA accumulation of the oncogene hWAPL.

Authors:  Masahiko Kuroda; Kosuke Oikawa; Keiichi Yoshida; Aya Takeuchi; Masaru Takeuchi; Masahiko Usui; Akihiro Umezawa; Kiyoshi Mukai
Journal:  Cancer Lett       Date:  2005-04-18       Impact factor: 8.679

6.  GSTM1, GSTT1, and NQO1 polymorphisms in cervical carcinogenesis.

Authors:  Osamu Nunobiki; Masatsugu Ueda; Hikari Akise; Shinji Izuma; Kiyo Torii; Yoshiaki Okamoto; Ichiro Tanaka; Sadamu Noda; Kyoko Akashi; Taro Higashida
Journal:  Hum Cell       Date:  2015-02-20       Impact factor: 4.174

7.  Activation of the canonical Wnt pathway during genital keratinocyte transformation: a model for cervical cancer progression.

Authors:  Aykut Uren; Shannon Fallen; Hang Yuan; Alp Usubütün; Türkan Küçükali; Richard Schlegel; Jeffrey A Toretsky
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

8.  Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.

Authors:  Geza Acs; Paul J Zhang; Cindy M McGrath; Peter Acs; John McBroom; Ahmed Mohyeldin; Suzhen Liu; Huasheng Lu; Ajay Verma
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

Review 9.  The epidemiology of cervical carcinogenesis.

Authors:  M H Schiffman; L A Brinton
Journal:  Cancer       Date:  1995-11-15       Impact factor: 6.860

10.  ALDH2 polymorphism for the risk of cervical carcinogenesis.

Authors:  Osamu Nunobiki; Daisuke Sano; Kyoko Akashi; Taro Higashida; Toshitada Ogasawara; Hikari Akise; Shinji Izuma; Kiyo Torii; Yoshiaki Okamoto; Ichiro Tanaka; Masatsugu Ueda
Journal:  Hum Cell       Date:  2016-02-03       Impact factor: 4.174

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.